In the breast, IRF6 was initially shown to directly interact with maspin, a tumor suppressor, in an immortalized normal mammary epithelial cell line, 1436N1, and have a decreased expression in invasive breast cancer cell lines and breast tumors [6]. This evidence concerns the gene IRF6 and neoplasm.